DANTE trial reveals promising outcomes for shortened immunotherapy in advanced melanoma

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control when compared to giving treatments over a longer period, according to breakthrough research…

Continue ReadingDANTE trial reveals promising outcomes for shortened immunotherapy in advanced melanoma